0

Coronary Risk Factors Collection
 61-80 of 2021 Articles
Editorials |  20 October 2015
Celebrating the ACP Centennial: From the Annals Archive—Alcohol and DiabetesCelebrating the ACP Centennial
Deborah Cotton, MD, MPH
Ann Intern Med. 2015;163(8):639. doi:10.7326/M15-1747
Original Research |  20 October 2015
Effects of Initiating Moderate Alcohol Intake on Cardiometabolic Risk in Adults With Type 2 Diabetes: A 2-Year Randomized, Controlled TrialTwo-Year Moderate Alcohol Intervention in Adults With Type 2 Diabetes
Yftach Gepner, MPH; Rachel Golan, RD, PhD; Ilana Harman-Boehm, MD; et al.
Ann Intern Med. 2015;163(8):569-579. doi:10.7326/M14-1650
Clinical Guidelines |  20 October 2015 FREE
Behavioral and Pharmacotherapy Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Women: U.S. Preventive Services Task Force Recommendation StatementUSPSTF Recommendation Statement for Interventions for Tobacco Smoking Cessation
Albert L. Siu, MD, MSPH; for the U.S. Preventive Services Task Force
Ann Intern Med. 2015;163(8):622-634. doi:10.7326/M15-2023
Reviews |  20 October 2015 FREE
Behavioral Counseling and Pharmacotherapy Interventions for Tobacco Cessation in Adults, Including Pregnant Women: A Review of Reviews for the U.S. Preventive Services Task ForceInterventions for Smoking Cessation
Carrie D. Patnode, PhD, MPH; Jillian T. Henderson, PhD, MPH; Jamie H. Thompson, MPH; et al.
Ann Intern Med. 2015;163(8):608-621. doi:10.7326/M15-0171
Ideas and Opinions |  15 September 2015
Using Agent-Based Models to Address “Wicked Problems” Like Tobacco Use: A Report From the Institute of MedicineUsing Agent-Based Models to Address Tobacco Use
Nancy A. Rigotti, MD; Robert B. Wallace, MD, MSc
Ann Intern Med. 2015;163(6):469-471. doi:10.7326/M15-1567
Editorials |  15 September 2015 FREE
Diabetes Prevention at the Tipping Point: Aligning Clinical and Public Health RecommendationsDiabetes Prevention at the Tipping Point
Ronald T. Ackermann, MD, MPH
Ann Intern Med. 2015;163(6):475-476. doi:10.7326/M15-1563
Clinical Guidelines |  15 September 2015 FREE
Combined Diet and Physical Activity Promotion Programs for Prevention of Diabetes: Community Preventive Services Task Force Recommendation StatementTask Force Statement on Diabetes Prevention With Diet and Physical Activity
Nicolaas P. Pronk, PhD; Patrick L. Remington, MD, MPH; on behalf of the Community Preventive Services Task Force
Ann Intern Med. 2015;163(6):465-468. doi:10.7326/M15-1029
Reviews |  15 September 2015 FREE
Economic Evaluation of Combined Diet and Physical Activity Promotion Programs to Prevent Type 2 Diabetes Among Persons at Increased Risk: A Systematic Review for the Community Preventive Services Task ForceEconomics of Lifestyle Prevention of Type 2 Diabetes
Rui Li, PhD; Shuli Qu, MPH; Ping Zhang, PhD; et al.
Ann Intern Med. 2015;163(6):452-460. doi:10.7326/M15-0469
Reviews |  15 September 2015 FREE
Combined Diet and Physical Activity Promotion Programs to Prevent Type 2 Diabetes Among Persons at Increased Risk: A Systematic Review for the Community Preventive Services Task ForceCombined Diet and Physical Activity Promotion Programs to Prevent Diabetes
Ethan M. Balk, MD, MPH; Amy Earley, BS; Gowri Raman, MD, MS; et al.
Ann Intern Med. 2015;163(6):437-451. doi:10.7326/M15-0452
Editorials |  1 September 2015
Celebrating the ACP Centennial: From the Annals Archive—Blood Pressure VariationCelebrating the ACP Centennial
Deborah Cotton, MD, MPH
Ann Intern Med. 2015;163(5):389. doi:10.7326/M15-1637
Letters |  18 August 2015
What Should We Regard as an “Elevated” C-Reactive Protein Level?
Irving Kushner, MD; Maria J. Antonelli, MD
Ann Intern Med. 2015;163(4):326. doi:10.7326/L15-5126
Beyond the Guidelines |  18 August 2015
Treatment of Blood Cholesterol to Reduce Risk for Atherosclerotic Cardiovascular Disease: Grand Rounds Discussion From the Beth Israel Deaconess Medical CenterCholesterol Treatment to Reduce Cardiovascular Risk
Murray A. Mittleman, MD; William C. Taylor, MD; Gerald Smetana, MD; et al.
Ann Intern Med. 2015;163(4):280-290. doi:10.7326/M15-1125
Clinical Guidelines |  18 August 2015 FREE
Management of Dyslipidemia for Cardiovascular Disease Risk Reduction: Synopsis of the 2014 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice GuidelineVA/DoD 2014 Cholesterol Guidelines
John R. Downs, MD; Patrick G. O'Malley, MD, MPH
Ann Intern Med. 2015;163(4):291-297. doi:10.7326/M15-0840
Ideas and Opinions |  18 August 2015
Enhancing Cognitive Aging: Clinical Highlights of a Report From the Institute of MedicineEnhancing Cognitive Aging
Sharon K. Inouye, MD, MPH
Ann Intern Med. 2015;163(4):307-310. doi:10.7326/M15-1228
Original Research |  7 July 2015
Long-Term Prognosis After Coronary Artery Calcification Testing in Asymptomatic Patients: A Cohort StudyLong-Term Prognosis After CAC Testing in Asymptomatic Patients
Leslee J. Shaw, PhD; Ashley E. Giambrone, PhD; Michael J. Blaha, MD; et al.
Ann Intern Med. 2015;163(1):14-21. doi:10.7326/M14-0612
Editorials |  7 July 2015
Celebrating the ACP Centennial: From the Annals Archive—Smoking CessationCelebrating the ACP Centennial
Deborah Cotton, MD, MPH, Deputy Editor
Ann Intern Med. 2015;163(1):63. doi:10.7326/M15-1145
In the Balance |  7 July 2015
Electronic Cigarettes: Aggregate HarmE-Cigarettes: Aggregate Harm
Thaddeus Bartter, MD
Ann Intern Med. 2015;163(1):59-60. doi:10.7326/M15-0450
In the Balance |  7 July 2015
Electronic Cigarettes: Perhaps the Devil Unknown Is Better Than the Devil KnownE-Cigarettes: Perhaps the Devil Unknown Is Better Than the Devil Known
M. Bradley Drummond, MD, MHS
Ann Intern Med. 2015;163(1):61-62. doi:10.7326/M15-0361
Editorials |  7 July 2015 FREE
PCSK9 Inhibitors: A New Era in Lipid-Lowering Treatment?PCSK9 Inhibitors: A New Era in Lipid-Lowering Treatment?
Miguel Cainzos-Achirica, MD; Seth S. Martin, MD, MHS; John E. Cornell, PhD; et al.
Ann Intern Med. 2015;163(1):64-65. doi:10.7326/M15-0920
Reviews |  7 July 2015 FREE
Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia: A Systematic Review and Meta-analysisEffects of PCSK9 Antibodies in Adults With Hypercholesterolemia
Eliano Pio Navarese, MD, PhD; Michalina Kołodziejczak, MD; Volker Schulze, MD; et al.
Ann Intern Med. 2015;163(1):40-51. doi:10.7326/M14-2957
Advertisement
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)